Target intelligence / Profile preview

Neuronal and glial networks

Molecular classification
Other
01

Overview

Neuronal and glial networks constitute the fundamental functional units of the central nervous system, comprising neurons that transmit electrical signals and glial cells—including astrocytes, microglia, and oligodendrocytes—that provide essential structural, metabolic, and signaling support (Verkhratsky & Nedergaard, 2018). These networks operate through complex interactions, such as the tripartite synapse, where astrocytes actively modulate synaptic activity by sensing and releasing neurotransmitters (Perea et al., 2009). In many neurological disorders, including Alzheimer's disease, epilepsy, and stroke, the coordinated activity of these networks is disrupted, often involving neuroinflammation and glial scarring (Burda & Sofroniew, 2014). While neuronal and glial networks is not a single molecular target, therapeutic strategies often aim to modulate these systems by targeting specific receptors (e.g., NMDA receptors), transporters (e.g., EAATs), or signaling pathways within the network to restore homeostatic balance (Nedergaard & Bewernick, 2020). Consequently, drug development in this area focuses on multi-target approaches or system-level modulation to address the multifaceted nature of brain pathology (Stahl, 2013).

Other names
Neuro-glial interactionsTripartite synapseBrain circuitryNeuro-glial unitNeuronal-glial syncytium
02

Mechanism of action

Modulation of synaptic transmission, glial-mediated neuroprotection, or neurotransmitter reuptake within the neuro-glial unit to restore network stability.

03

Biological functions

Signal transductionSynaptic transmissionHomeostasisNeurovascular couplingMetabolic supportSynaptic pruning
04

Disease associations

Neurodegenerative diseaseEpilepsyNeuroinflammationPsychiatric disorderStrokeMultiple sclerosis
05

Safety considerations

Global cognitive impairmentDisruption of homeostatic balanceSeizure riskOff-target CNS effectsBlood-brain barrier permeability changes
06

Interacting drugs

Memantine

5 more in the full profile.

07

Biomarkers

Glial Fibrillary Acidic Protein (GFAP)Neurofilament Light Chain (NfL)Functional MRI (fMRI) connectivityElectroencephalography (EEG) patternsS100B

Beyond the preview

Go deeper on Neuronal and glial networks.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuronal and glial networks.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call